FDA Drug Application (022314) for EXFORGE HCT by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number022314
Product Number001
FormTABLET;ORAL
Dosage5MG;12.5MG;160MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEXFORGE HCT
Active IngredientAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE BESYLATE21
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient VALSARTAN12


Back to FDA Applications sponsored by NOVARTIS